Eriksson J, Lönnroth P, Wesslau C, Smith U
Department of Medicine II, University of Göteborg, Sahlgren's Hospital, Gothenburg, Sweden.
Biochem Biophys Res Commun. 1991 May 15;176(3):1277-84. doi: 10.1016/0006-291x(91)90424-6.
To investigate the mechanisms by which amiloride inhibits insulin action rat adipocytes were treated with insulin and with amiloride added before or after energy depleting the cells with 2 mM KCN. Amiloride decreased the insulin response on 3-0-methylglucose transport, IGF-II- and insulin binding in both intact and energy depleted cells. In contrast, the sensitivity to insulin was inhibited by amiloride only when it was added before KCN. The effect of amiloride on insulin sensitivity was probably exerted through the impaired activation of the insulin receptor tyrosine kinase and the decreased insulin binding. However, insulin responsiveness was probably impaired through a direct effect on the plasma membrane proteins. In contrast to a recent report with pituitary cells, amiloride did not affect the activation of the inhibitory GTP-binding protein (Gi) in rat adipocytes.
为研究氨氯吡咪抑制胰岛素作用的机制,在用2 mM氰化钾使细胞能量耗竭之前或之后,将大鼠脂肪细胞分别用胰岛素和添加了氨氯吡咪的溶液进行处理。氨氯吡咪降低了完整细胞和能量耗竭细胞对3-0-甲基葡萄糖转运、胰岛素样生长因子-II(IGF-II)及胰岛素结合的胰岛素反应。相比之下,仅当在加入氰化钾之前添加氨氯吡咪时,其才会抑制对胰岛素的敏感性。氨氯吡咪对胰岛素敏感性的影响可能是通过胰岛素受体酪氨酸激酶激活受损和胰岛素结合减少来实现的。然而,胰岛素反应性可能是通过对质膜蛋白的直接作用而受损。与最近一篇关于垂体细胞的报道不同,氨氯吡咪不影响大鼠脂肪细胞中抑制性GTP结合蛋白(Gi)的激活。